Methylphenidate Transdermal Patch (Daytrana), ADHD, & the FDA: FDA Briefing Information

Briefing Information for the FDA's psychopharmacologic drugs advisory committee meeting on Friday.
-
Anthony H. Risser
neuroscience | neuropsychology | brain | ADHD

Comments

Summer Session begins next week for me. I am teaching several courses that I much enjoy: Introduction to Clinical Neuropsychology, Psychopharmacology, Cognitive, and Clinical Neuroscience. Let the sun shine and the coffee flow!

BrainBlog

Search This Blog

Methylphenidate Transdermal Patch (Daytrana), ADHD, & the FDA: FDA Briefing Information

Comments

Popular posts from this blog

Welcome to Fall Semester!

Welcome to Summer Session!